MARK3 and breast carcinoma: In this study, we found a higher PSI value in breast cancer patients than in normal samples for COMMD4_AS2, GNAS, MATR3, RHOC and COMMD4_AS1, whereas the PSI value was lower for MARK3, POLDIP3 and FASTK.